Global versus focused isolation during the SARS-CoV-2 pandemic-A cost-effectiveness analysis

Amir Shlomai, Ari Leshno, Ella H. Sklan, Moshe leshno
doi: https://doi.org/10.1101/2020.03.30.20047860

Article Information

doi 
https://doi.org/10.1101/2020.03.30.20047860
History 
  • April 1, 2020.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Amir Shlomai1,
  2. Ari Leshno2,
  3. Ella H. Sklan3,*,+ and
  4. Moshe leshno4,*
  1. 1Department of Medicine D and The Liver Institute, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel and The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
  2. 2Goldschleger Eye Institute, Sheba Medical Center, Ramat Gan, Israel and The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
  3. 3Department of Clinical Microbiology and Immunology, The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
  4. 4The Coller School of Management, Tel Aviv University, Tel Aviv, Israel
  1. ↵+Corresponding author Ella H. Sklan sklan{at}tauex.tau.ac.il

  1. ↵* equal contribution

Back to top
Posted April 01, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Global versus focused isolation during the SARS-CoV-2 pandemic-A cost-effectiveness analysis
Amir Shlomai, Ari Leshno, Ella H. Sklan, Moshe leshno
medRxiv 2020.03.30.20047860; doi: https://doi.org/10.1101/2020.03.30.20047860
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area